Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.Donate to our crowdfunder
The Joint Committee on Vaccination and Immunisation (JCVI), advises Ministers on immunisation related issues, is currently in the process of considering the impact and cost-effectiveness of extending the human papillomavirus (HPV) vaccination to adolescent boys.
The JCVI will need to consider mathematical modelling by Public Health England (PHE) on the impact and cost effectiveness of extending the HPV vaccination to adolescent boys, ahead of developing its advice. PHE is expected to report its modelling assessment to the Committee in early 2017.
The JCVI will consider the analysis from PHE at the earliest opportunity. Once the Committee is satisfied it has reviewed all the necessary evidence it will then be expected to make its advice.